» Articles » PMID: 33638691

In Vitro Effects of the Endocrine Disruptor P,p'DDT on Human Choriogonadotropin/luteinizing Hormone Receptor Signalling

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2021 Feb 27
PMID 33638691
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Dichlorodiphenyltrichloroethane (p,p'DDT) is an endocrine-disrupting chemical (EDC). Several studies showed an association between p,p'DDT exposure and reprotoxic effects. We showed that p,p'DDT was a positive allosteric modulator of human follitropin receptor (FSHR). In contrast, we demonstrated that p,p'DDT decreased the cyclic AMP (cAMP) production induced by human choriogonadotropin (hCG). This study evaluated further the effects of p,p'DDT on Gs-, β-arrestin 2- and steroidogenesis pathways induced by hCG or luteinizing hormone (LH). We used Chinese hamster ovary cells line stably expressing hCG/LHR. The effects of 10-100 µM p,p'DDT on cAMP production and on β-arrestin 2 recruitment were measured using bioluminescence and time-resolved resonance energy transfer technology. The impact of 100 µM of p,p'DDT on steroid secretion was analysed in murine Leydig tumor cell line (mLTC-1). In cAMP assays, 100 µM p,p'DDT increased the EC by more than 300% and reduced the maximum response of the hCG/LHR to hCG and hLH by 30%. This inhibitory effect was also found in human granulosa cells line and in mLTC-1 cells. Likewise, 100 µM p,p'DDT decreased the hCG- and hLH-promoted β-arrestin 2 recruitment down to 14.2 and 26.6%, respectively. Moreover, 100 µM p,p'DDT decreased by 30 and 47% the progesterone secretion induced by hCG or hLH, respectively, without affecting testosterone secretion. This negative effect of p,p'DDT was independent of cytotoxicity. p,p'DDT acted as a negative allosteric modulator of the hCG/LHR signalling. This emphasizes the importance of analyzing all receptor-downstream pathways to fully understand the deleterious effects of EDC on human health.

Citing Articles

Benzo[a]pyrene disrupts LH/hCG-dependent mouse Leydig cell steroidogenesis through receptor/Gαs protein targeting.

Lazzaretti C, Roy N, Paradiso E, Capponi C, Ferrari T, Reggianini F Sci Rep. 2024; 14(1):844.

PMID: 38191651 PMC: 10774265. DOI: 10.1038/s41598-024-51516-7.


Effects of Dichlorodiphenyltrichloroethane on the Female Reproductive Tract Leading to Infertility and Cancer: Systematic Search and Review.

Syed S, Qasim S, Ejaz M, Sammar , Khan N, Ali H Toxics. 2023; 11(9).

PMID: 37755736 PMC: 10536953. DOI: 10.3390/toxics11090725.


Allosteric modulation of gonadotropin receptors.

Lazzaretti C, Simoni M, Casarini L, Paradiso E Front Endocrinol (Lausanne). 2023; 14:1179079.

PMID: 37305033 PMC: 10248450. DOI: 10.3389/fendo.2023.1179079.


10 M genistein partially alleviates 10 M MEHP unfavorable effects in a new modified fetal rat testis culture system.

Zhang T, Ma Y, Gao M, Li H, Wang Z, Chong T Front Cell Dev Biol. 2022; 10:987928.

PMID: 36105356 PMC: 9465295. DOI: 10.3389/fcell.2022.987928.

References
1.
Aamir M, Khan S, Li G . Dietary exposure to HCH and DDT congeners and their associated cancer risk based on Pakistani food consumption. Environ Sci Pollut Res Int. 2018; 25(9):8465-8474. DOI: 10.1007/s11356-017-1129-1. View

2.
Al-Hussaini T, Abdelaleem A, Elnashar I, Shabaan O, Mostafa R, El-Baz M . The effect of follicullar fluid pesticides and polychlorinated biphenyls concentrations on intracytoplasmic sperm injection (ICSI) embryological and clinical outcome. Eur J Obstet Gynecol Reprod Biol. 2017; 220:39-43. DOI: 10.1016/j.ejogrb.2017.11.003. View

3.
Al-Saleh I, Coskun S, El-Doush I, Billedo G, Mashhour A, Jaroudi K . Outcome of in-vitro fertilization treatment and DDT levels in serum and follicular fluid. Med Sci Monit. 2009; 15(11):BR320-33. View

4.
Aneck-Hahn N, Schulenburg G, Bornman M, Farias P, de Jager C . Impaired semen quality associated with environmental DDT exposure in young men living in a malaria area in the Limpopo Province, South Africa. J Androl. 2006; 28(3):423-34. DOI: 10.2164/jandrol.106.001701. View

5.
Ascoli M, Fanelli F, Segaloff D . The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002; 23(2):141-74. DOI: 10.1210/edrv.23.2.0462. View